|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 255/51 | |
| A61K 31/167 | |||
| A61P 15/16 | |||
| C07C 255/60 |
| (11) | Patento numeris | 3147278 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16194602.5 |
| Europos patento paraiškos padavimo data | 2007-07-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 830158 P | 2006-07-12 | US | |
| 839665 P | 2006-08-24 | US | |
| 907748 P | 2007-04-16 | US |
| (72) |
DALTON, James T., US
MILLER, Duane D., US
|
| (73) |
University of Tennessee Research Foundation,
211 Conference Center Building 600 Henley Street, Knoxville, TN 37996,
US
|
| (54) | COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS |
| COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS |